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Staphylococcal  nuclease is  a well-characterized  protein  antigen that has  been 
used in  our laboratory  for  a variety  of  studies  on the genetic  control  of  immune 
responses (1).  Rat  antisera  detecting  binding  site-specific  idiotypic  determinants 
of anti-nuclease antibodies have been used to study the genetics of variable 
region  genes (2-4).  Thus, genes determining the predominant idiotype  produced 
in  A/J mice in response to nuclease were found to  be linked to the heavy chain 
allotype  locus,  were subject  to  recombination with respect  to  this  locus  at  a high 
frequency, and were independent ofH-2-1inked Ir genes in  their  expression (3, 
4). In a preliminary study (3),  it was shown that there existed at least  two 
distinct  noncross-reacting  idiotypes  determined by genes linked to heavy chain 
allotype linkage group (IgCH)  I characteristic  of strain A/J (IgCH  e) or SJL 
(IgCHb). These two idiotypes  were both present in immune sera from strain 
BALB/c (IgCHa), but they were absent from sera  of  strain  CB.20 (IgCHb). The 
strain BAB.14 (IgCHb), a recombinant strain  which was produced during the 
transfer  of  the IgCH  b  allotype  locus  of  B6 to  the BALB/c background, bore only 
the A/J idiotype.  This result  suggested that  the recombinational event in the 
BAB.  14 occurred within the gene segment which codes for variable  regions  of 
the immunoglobulin  heavy chain (VH) rather than between constant region 
(CH)  and VH genes as had been inferred  from other studies  (5-7). 
A genetic  map of  VH region genes in the BALB/c strain  was proposed as: 
A/JaNase- SJLaNase- IgCH  a 
where A/JaNase and SJLaNase represent loci for genes determining A/J and 
SJL  anti-nuclease  idiotypes,  respectively,  and  IgCI-1  ~  represents  the  heavy 
chain allotype linkage group of BALB/c (8). From these studies, however, it 
was not possible to determine whether the A/J and SJL idiotypes were directed 
against the same or different antigenic determinants, or whether in fact they 
were on the same or different molecules. To answer some of these questions, 
1Abbreviations  used  in  this paper: BSA,  bovine serum a|bumin; CFA,  complete Freund's 
adjuvant; CH,  constant region of the immunoglobulin  heavy chain; CNBr,  cyanogen bromide; 
IgCH,  heavy chain allotype linkage group;  VH,  variable region of the irnmunoglobulin  heavy 
chain. 
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anti-nuclease antibodies from various strains have been fractionated into two 
populations  on  the  basis  of their  ability  to bind  to  a  fragment  of nuclease 
comprising the 99th-149th amino acids.  By analysis  of the idiotypes in these 
two fractions, the map order for strain BALB/c has been confirmed, and at least 
three  new  idiotypic  markers  have  been  identified,  allowing  additional  map 
positions  to be  assigned.  These  results  and  analyses  are  the  subject of this 
report. 
Materials and Methods 
Mice.  A/J mice were purchased from The Jackson Laboratory, Bar Harbor, Maine; SJL mice 
from Texas Inbred  Mice Co.,  Houston,  Texas; and  BALB/c from National Institutes of Health 
Animal Production.  CB.20 mice were a  gift of Dr.  M.  Potter of the National Cancer Institute. 
BAB.14 mice were a  gift of Dr. M. Weigert, Institute for Cancer Research, Philadelphia,  Penn- 
sylvania. All mice were males except those of strain SJL. 
Rats.  Adult male Lewis rats were purchased from Microbiological Associates, Walkersville, 
Md. 
Preparation of  Anti-Nuclease Antibodies.  Groups of 5-25 mice were immunized with 10O/~g of 
purified nuclease in complete Freund's adjuvant (CFA) and boosted weekly with 10/~g ofnuclease 
in saline beginning on the 3rd wk after immunization. For the experiments reported here, pooled 
hyperimmune sera obtained after the 4th and 5th boost were used. 
Preparation ofAnti-ldiotypic  Antisera.  Lewis rats were immunized every 2 wk with 500 ~tg of 
affinity column-purified anti-nuclease antibodies in CFA. Sera from individual animals showing 
the highest activity were used in these experiments. 
Assay of  Anti-Nuclease Antibodies.  The assay of anti-nuclease antibodies has been previously 
described (9). Briefly, the ability of anti-nuclease antibodies to inactivate the enzymatic activity 
of nuclease was determined  at increasing dilutions of serum,  and  the plateau  value for units 
inactivated per milliliter of antiserum was calculated. 
Assay for the Presence of  ldiotypes in Anti-Nuclease Antibodies.  The details of this assay have 
been  previously  reported  (2).  Briefly,  the  ability  of  anti-idiotypic  antisera  to  inhibit  the 
inactivation of nuclease by antibodies was determined.  To perform the assay,  an anti-nuclease 
preparation was preincubated with anti-idiotypic antiserum for 5 min, and then incubated with 
nuclease. The units inactivated were determined and then compared to an identical amount of 
anti-nuclease  antibody  preincubated  with  0.1%  bovine  serum  albumin  (BSA)  in  saline.  The 
inhibitory activity of the anti-idiotypic antisera was calculated using the formula 
% inhibition =  A(Nase +  aNaso +  aiD) -  A(Nase +  aNase) 
A(Nase)  -  A(Nase +  aNase) 
in which A(Nase  +  aNase  +  aiD) indicates the activity measured  in the presence of nuclease 
(Nase), antibody (aNase), and anti-idiotype (aiD), etc., as previously described. In all cases, the 
final dilutions of the antibody preparations  used had comparable activities in terms of units of 
nucleaso inactivated. Results presented were obtained from at least duplicate determinations on 
each antibody preparation.  An antibody preparation was considered to contain a given idiotype if 
the anti-idiotype produced statistically significant (P <  0.05)  inhibition of inactivation. 
Preparation of Nuclease Fragment (99-149).  The nuclease fragment comprising the carboxy 
terminal  99th-149th  amino  acids  was  prepared  according  to  published  methods  (10). Briefly, 
nuclease was degraded with cyanogen bromide (CNBr) and the resulting cleavage products were 
separated by gel filtration chromatography on Sephadex G-50. The major peak with absorbance at 
280  nm was  then  chromatographed  twice on phosphocellulose,  developing the  column with  a 
linear elution gradient of ammonium acetate 0.1 M, pH 3, to 1.0 M, pH 8. Purity of the resulting 
peptide was assessed by use of a complementation assay in which the ability of nuclease fragment 
(99-149) to combine with nuclease fragment (1-126) to form an enzymatically active structure was 
determined (11). By comparison with a preparation of fragment (99-149) of known purity, a purity 
of---90% was determined for the preparation used in these experiments. 
Fractionation of Anti-Nuclease Antibodies.  To separate antibodies capable of binding to the 
fragment  (99-149),  affinity chromatography  was  employed.  Fragment  (99-149) was  coupled  to DAVID  S.  PISETSKY  AND  DAVID  H.  SACHS 
TABLE  I 
Strains Used in the Present Study 
H-2  Anti-nuclease 
Strain  Allotype  Haplotype  idiotypes 
A/J  a  e  A/J 
SJL  s  b  SJL 
B10.A  a  b  B10 
BALB/c  d  a  A/J, SJL 
CB.20  d  b  B10 
BAB. 14  d  b  AJJ 
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CNBr-activated Sepharose 4B as previously described (12).  Hyperimmune sera were passed over 
this  column.  The  antibodies  not  binding  were  considered  to  be  devoid  of  specificities  for 
determinants represented on the fragment and were termed anti-nuclease (1-99)N, in which the 
subscript N indicates that the antibodies were prepared against intact, native nuclease, according 
to previously established conventions (13).  To remove bound antibodies, the column was eluted 
with 0.5 M guanidine, 0.01 M  KPO4, pH 7, containing 0.1% BSA. The material obtained by this 
elution method was termed anti-nuclease (99-149)N. Fractionated antibody preparations could be 
stored at -20°F without loss of activity for at least 2 mo. 
Results 
Fractionation of Antibodies.  The  fractionation  Procedure used  in  these 
experiments is based on the ability of antibodies prepared against the native 
form of a  protein antigen to bind to a  peptide fragment of the protein. This 
approach  has  been  previously  used  in  fractionation  of goat  anti-nuclease 
antibodies to yield preparations of restricted heterogeneity (12), and a theoreti- 
cal basis for this fractionation has been described in terms of  the conformational 
equilibrium of the peptide in solution (14). The peptide used in these studies, 
nuclease (99-149), comprises the carboxy terminal 99th to 149th amino acids of 
nuclease. 
Table I lists the strains used in these studies along with their H-2 haplotype, 
CH allotype, and known anti-nuclease idiotypes. Antibodies from these strains 
were fractionated into anti-nuclease (99-149)N and anti-nuclease (1-99)N fractions 
as described in Materials and Methods. Various eluting conditions were tested 
for their ability to remove bound antibodies from the column; the most stable 
and active preparations were obtained using 0.5 M guanidine containing 0.1% 
BSA. Higher concentrations of guanidine or other chaotropic agents were able 
to remove slightly more bound protein, but the resulting preparations were less 
active. With the elution conditions described, the anti-nuclease (99-149)N frac- 
tion contained from 2 to 6% of the inactivating capacity of the unfractionated 
sera for the strains examined. In contrast, anti-nuclease (99-149)N preparations 
from goat anti-nuclease antisera comprised 11.5% of the total antibodies (12). It 
has not yet been determined whether in mice anti-nuclease (99-149)N antibodies 
represent a smaller percentage of the total anti-nuclease response than in the 
goat,  or  whether the  mouse  antibodies  have become denatured during the 
fractionation procedures yielding preparations of lower specific activity. 
Idiotype Analysis of Antibody Preparations.  The idiotypes present in frac- 
tionated and unfractionated antibodies of the five strains tested were assayed 
by  use  of  antisera  prepared  in  Lewis  rats  against  purified  anti-nuclease 1520  MAPPING  OF  GENES  FOR  ANTI-NUCLEASE  IDIOTYPES 
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FZG. i.  Determination of  anti-nuclease idiotypes  by inhibition  of antibody inactivation. 
Anti-nuclease  antibodies from  strains A/J,  SJL,  BALB/c,  CB.20,  and BAB.14  were 
fractionated  into  anti-nuclease (1-99)N  and anti-nuclease (99-149)N  as  described in  Materials 
and Methods. Fractionated antibody preparations as well as unfractionated antisera were 
tested with anti-idiotypic  antisera specific  for A/J, SJL, BALB/c,  or B10.A(2R) anti- 
nuclease antibodies.  Results are plotted  in terms of  the percentage of  antibody-mediated 
inactivation  that is  inhibited  by the anti-idiotypic  antisera. DAVID  8.  PISETSKY  AND  DAVID  H.  8ACH8  1521 
antibodies  from strains  A/J, SJL, BALB/c, and BI0.A(2R). BI0.A(2R) is  a high 
responder strain  with a recombinant H-2 haplotype on the B10 background. 
Since H-2 type has been found not to influence  idiotype  expression  (3),  the 
markers recognized by this  sera will be referred  to (for  simplicity)  as B10 
idiotypes. 
Fig. 1 presents in graphic form the idiotype  analysis  of  the unfractionated 
antibodies as well as the anti-nuclease (1-99)N  and anti-nuclease (99-149)N 
preparations  from the strains  analyzed. The percent inhibition  of  inactivation 
produced  by  the  different  idiotypes  is  shown. It  is  apparent  from  this  figure  that 
each anti-idiotypic  antiserum was capable of  recognizing at least  two sets  of 
idiotypic  determinants, one  detected  in  the anti-nuclease  (1-99)N  population  and 
the other in the anti-nuclease (99-149)~  populations.  Thus, additional  anti- 
nuclease  idiotypes  can  be  defined  and distinguished  in  terms  of  the  specificity  of 
the antibodies,  i.e.  either  anti-nuclease  (I-99)N  or anti-nuclease  (99-149)N. 
Also  apparent  in  Fig. I  is  the  fact  that  in  all  cases,  the  pattern  of  reactivity  of 
the anti-nuclease (1-99)s  fraction  was the same as that of unfractionated 
antibodies. This result was interpreted to indicate that the inhibition  of 
nuclease inactivation  assay for  idiotypes  detects  only those  idiotypes  present  in 
highest concentration.  Studies  by Berzofsky et al. (15)  showed that within the 
anti-nuclease  sera of  strains  A/J, SJL, and B10.A, antibodies  with specificity 
for fragment (99-149)  were less  abundant than antibodies  with specificity  for 
fragment (1-126).  Since  anti-nuclease  (1-99)s  should be  of  similar  composition  to 
anti-nuclease (1-126)N,  this  result is consistent with our observation that 
idiotypes  of  anti-nuclease  (1-99)~  were more readily  detected  in unfractionated 
antisera  than idiotypes  of  anti-nuclease  (99-149)N. 
The most surprising  and, perhaps, important result  seen in Fig. 1 was that 
the pattern of  reactivity  with the anti-idiotypic  antisera  of  the anti-nuclease 
(99-149)N and  anti-nuclease  (1-99)s antibody populations differed for  several 
strains. The following differences were noted. (a) Anti-nuclease (1-99)N antibod- 
ies from strains SJL and BALB/c expressed cross-reacting idiotypes, whereas 
anti-nuclease (99-149)N antibodies from the same strains did not. This result 
was  obtained  using  anti-idiotypic  antisera  prepared  against  either  SJL  or 
BALB/c antibodies.  (b) Anti-nuclease (99-149)N from CB.20 and SJL shared a 
cross-reacting idiotype, whereas the anti-nuclease  (1-99)N antibodies did not. 
Again,  an  identical  result  was  obtained  using  the  anti-idiotypic  antisera 
prepared  against  SJL  or  B10.A(2R)  antibodies.  (c)  Unlike  BALB/c,  strain 
BAB.14 expressed an anti-nuclease (99-149)N idiotype that cross-reacted with 
anti-nuclease (99-149)N from CB.20 and SJL. On the basis of these results, five 
distinct patterns of reactivity of antibody populations with the anti-idiotypic 
antisera  could be  distinguished.  The  idiotypes thus  identified were  termed 
NASE idiotypes and were identified by sequential letters A through E  (Table 
1I). 
Discussion 
The results presented in this communication confirm and extend our previous 
finding on the strain distribution of anti-nuclease idiotypes. By fractionation of 
antibodies to individual antigenic regions of the nuclease molecules, we have 1522  MAPPING  OF  GENES  FOR  ANTI-NUCLEASE IDIOTYPES 
TABLE II 
Strain Distribution of NASE Idiotype Markers 
Antigenic determi-  Idiotype  Positive strains 
nant  markers 
Nuclease  (1-99)  N  NASE-A  A/J, BALB/c,  BAB.14 
NASE-B  SJL, BALB/c 
NASE-C  CB.20, B10 
Nuclease  (99-149)N  NASE-D  A/J, BALB/c, BAB.14 
NASE-E  SJL, CB.20, B10, BAB.14 
Various anti-nuclease  idiotypes,  designated  NASE markers,  are listed 
along with their strain distribution and the antigenic region to which 
they are directed. 
•  •  ,,  /  •  • 
Nase-A*  Nase-D*  ~v,  Nase-B  Ig-I  a 
Nase-C  Nase-E  Ig-1  b 
BALB/c 
CIB.20 
•  m 
Nase-A*  Nase-D*  Nase-E  lg-1 b 
BAB.14 
FIG.  2.  Proposed  map  of genes  determining  anti-nuclease  idiotypes.  Map  positions  of 
genes for various NASE idiotype markers were assigned to account for results obtained on 
idiotype  determinations  of anti-nuclease  antisera  from strains  BALB/c, CB.20,  and the 
recombinant strain BAB.14.  Distances  with respect to the IgCH allotype locus as well as 
the relative positions of the NASE-A and NASE-D markers are arbitrary.  The recombina- 
tional event that resulted in the BAB.14 strain is shown as involving the strain CB.20, as 
this strain was the source  of antibodies used for the idiotype determinations.  * indicates 
that position of these markers relative to each other is arbitrary. 
been able to identify five distinct anti-nuclease idiotypes. These idiotypes can 
be  distinguished  by  the  antigenic  region to which they  are  directed  (either 
nuclease  [1-99] or  nuclease  [99-149]) and  by  their  strain  distribution.  This 
number of idiotypes represents the minimum number needed to account for the 
observed results, and it is likely an underestimate of the true number of anti- 
nuclease idiotypes present in immune sera. For each of five strains examined, a 
unique pattern of expression of these idiotypes has been identified. 
For three of these strains, BALB/c, CB.20,  and BAB.14, it is possible to map 
the  genes  that  determine  the different anti-nuclease  idiotypes.  To  construct 
such a map,  it is necessary that the genes determining these idiotypes all be 
linked to the C.  allotype locus.  Since these three strains  are congenic,  with 
known  genetic  differences only  at  the  C~  allotype  locus  and  closely  linked 
genes, the differences in their idiotype expression can be accounted for entirely 
on the basis  of the  linkage  of idiotype  genes  to the  C.  allotype  locus.  This 
linkage,  however,  does not imply that the structures recognized by the anti- 
idiotypic antisera are present exclusively on the heavy chain, nor that the gene 
linked to the CH allotype locus is a structural rather than a regulatory gene. 
Fig. 2 shows maps of idiotype genes for strains BALB/c, CB.20,  and BAB.14 DAVID  S.  PISETSKY  AND  DAVID  H.  SACHS  1523 
using the  NASE  idiotype markers defined in Table  II.  In these maps,  the 
recombination event that occurred during the development  of the BAB.14 strain 
is illustrated as involving the CB.20  strain,  since the CB.20  strain was the 
source of antibodies of the B6 allotype used in the idiotype determination. A 
precise designation of the actual strain involved in this event cannot be given, 
since the time of occurrence of the recombination is unknown. These maps 
indicate that the crossover point between the BALB/c and B6 (CB.20) chromo- 
somes occurred among the VH genes rather than between VH and CH genes. 
Two lines of evidence support this  placement: (a)  the  BAB.14  strain  has 
acquired the NASE-A and NASE-D markers from BALB/c, but not the NASE- 
B  marker;  (b)  the  BAB.14  strain  expressed  the  NASE-E  marker,  which 
indicates that VH region genes from B6 were acquired along with the IgCH b 
allotype locus.  Since the BAB. 14 strain has Vn genes from BALB/c and B6, the 
recombinational event must have occurred between different VH region genes. 
At present, the position of the NASE markers can be made only relative to the 
crossover point and the C H  allotype locus. The map distances between the gel~es, 
as well as the ordering of NASE-A and NASE-D as shown is arbitrary. Never- 
theless, such mapping is consistent with a linear array of VH region genes. 
These data also indicate that genes determining antibodies directed against 
the same antigenic regions of the nuclease molecule may have different map 
positions in different strains. Several examples are evident from our maps: (a) 
the  genes  determining  anti-nuclease  (99-149)N antibodies  in  strain  CB.20 
(NASE-E idiotype) are close to the allotype locus, whereas genes determining 
anti-nuclease (99-149)N antibodies in BALB/c  (NASE-D idiotype) are distant, 
being localized to the other side of crossover point; (b) genes determining anti- 
nuclease (1-99)N in BALB/c (NASE-B idiotype) are ~close to the allotype locus, 
whereas anti-nuclease (1-99)N idiotype in strain CB.20  (NASE-C)and strain 
BALB/c  (NASE-A) are both more distant,  distal to the postulated crossover 
point;  (c) in the BAB.14  strain,  genes for idiotypically distinct anti-nuclease 
(99-149)N idiotypes occur at different positions, on either side of the crossover 
point.  These results  are  similar  to  those obtained by Berek et  al.  (16) for 
mapping anti-streptococcal idiotypes, and they support the notion that genes for 
antibodies to  the same antigenic determinants may map at nonhomologous 
positions  in  different strains.  This  suggests that ' different anti-nuclease idi- 
otypes are not necessarily allelic. 
In a previous study (3), two interesting features of the strain distribution of 
anti-nuclease idiotypes were noted: first,  strain BALB/c  (IgCI-I  ~) shared idi- 
otypes with strain A/J (IgCH e) and SJL (IgCHb); and second, strain B10 (IgCH b) 
did not share idiotypes with strain SJL (IgCHb). From these data we speculated 
on possible mechanisms of gene evolution that could have led to this distribu- 
tion.  It  is clear from the  studies presented here that the  situation is more 
complex. Thus, whereas BALB/c mice have anti-nuclease (1-99)N idiotypes in 
common with both A/J and SJL, the anti-nuclease (99-149)N idiotypes are shared 
only with strain A/J. Similarly, although strains SJL and CB.20 do not share 
idiotypes for anti-nuclease (1-99)N antibodies, they do share an idiotype for anti- 
nuclease (99-149)N. These results suggest that genes coding for different antibod- 
ies to the same antigen may have evolved independently. For the B10 and SJL 1524  MAPPING  OF  GENES  FOR  ANTI-NUCLEASE  IDIOTYPES 
strains, two models to account for such independent evolutionary development 
can be suggested. In the first  model, one can postulate that both strains  derived 
from a common ancestor. As the strains  evolved, however, there was divergence 
of  only some of  the VH region genes that had been inherited in  common in such 
a manner that genes for  the anti-nuclease (1-99)N  idiotypes in  the two strains  no 
longer coded for  crose-reacting  idiotypes.  This sequence of  gene evolution would 
be consistent  with  allelism of genes  determining  antibodies  to the same 
antigenic region if  the genes for anti-nuclease (1-99)N  idiotypes in beth strains 
derived from the same ancestral genes. It is equally plausible, however, that 
the genes for  the two idiotypes  evolved from different  ancestral genes. Alterna- 
tively, in a second model, one can consider both strains to have evolved from 
different  ancestors with different  V-gene repertoires.  One can then propose that 
by convergent evolution, genes coding for  cross-reactive  anti-nuclease (99-149)N 
idiotypes emerged  in beth strains, although  not necessarily  at the same 
chromosomal location.  At the moment, the constraints placed upon this  evolu- 
tionary development  by CH allotype and other genes, e.g. immune  response 
genes or  genes coding for  light  chains, are unknown. It  is  hoped that  analysis of 
more idiotypic  markers will  give further insight into this  problem. 
Summary 
Antibodies to staphylococcal nuclease have been fractionated into  two popu- 
lations on the basis of  their ability  to bind to the cyanogen bromide cleavage 
product of  nuclease comprising the C-terminal portion of  the molecule from the 
99th to the 149th amino acid.  The two populations of  antibodies, anti-nuclease 
(1-99)N and anti-nuclease (99-149)~, have been prepared from a variety of strains, 
and analyzed using anti-idiotypic antisera raised against whole anti-nuclease 
antibodies from strains A/J,  SJL,  BALB/c, and B10.A(2R).  Anti-nuclease (1- 
99)N  antibodies  had  the  same  pattern  of reactivity  with  the  anti-idiotypic 
antisera  as  did  unfractionated  antibodies,  whereas a  different pattern  was 
found for anti-nuclease (99-149)N preparations.  On the basis of these studies, 
five anti-nuclease idiotypes, designated NASE markers, have been identified 
and defined on the basis of their antigenic specificity and strain distribution. 
With these additional markers, it has been possible to provide more detailed 
maps  of variable  (V)  region genes  in the  strains  BALB/c,  CB.20,  and  the 
recombinant BAB. 14. A recombinational event between V region genes during 
the development of the BAB. 14 strain is suggested by the positioning of these 
NASE markers. 
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